By Mariam Sunny April 6 (Reuters) – Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash,…
Year: 2026
Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout
By Mariam Sunny April 6 (Reuters) – Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash,…
Logan sketches path to shrink size of Fed balance sheet
By Michael S. Derby April 2 (Reuters) – Dallas Federal Reserve President Lorie Logan on Thursday laid out paths and…
Logan sketches path to shrink size of Fed balance sheet
By Michael S. Derby April 2 (Reuters) – Dallas Federal Reserve President Lorie Logan on Thursday laid out paths and…
Logan sketches path to shrink size of Fed balance sheet
By Michael S. Derby April 2 (Reuters) – Dallas Federal Reserve President Lorie Logan on Thursday laid out paths and…
E-commerce duties moratorium expires as WTO talks run out of time, officials say
By Olivia Le Poidevin YAOUNDE, March 30 (Reuters) – A global e-commerce moratorium on duties on digital downloads and streaming…
E-commerce duties moratorium expires as WTO talks run out of time, officials say
By Olivia Le Poidevin YAOUNDE, March 30 (Reuters) – A global e-commerce moratorium on duties on digital downloads and streaming…
E-commerce duties moratorium expires as WTO talks run out of time, officials say
By Olivia Le Poidevin YAOUNDE, March 30 (Reuters) – A global e-commerce moratorium on duties on digital downloads and streaming…
Ousted Ben & Jerry’s board chair sues Unilever, alleging defamation
By Jonathan Stempel March 26 (Reuters) – Unilever and its recently spun-off Magnum ice cream unit were sued for defamation…
Ousted Ben & Jerry’s board chair sues Unilever, alleging defamation
By Jonathan Stempel March 26 (Reuters) – Unilever and its recently spun-off Magnum ice cream unit were sued for defamation…